The Boston Biotech Conference (BBC) series is comprised of thought-leader forums for senior biotechnology and pharmaceutical executives. These exclusive forums are co-hosted by healthcare industry leaders to foster discussions and facilitate information sharing, networking and corporate development within the bio-pharma community in a uniquely intimate environment. The New York CEO Conference is a networking forum for industry CEOs and decision makers in life sciences. Attendees gain insights from presentations and panels featuring CEOs from several of the world's leading biopharmaceutical companies. Industry leaders in venture capital and private equity also participate.

WilmerHale Partner Steve Singer will be moderating a panel on private healthcare, featuring speakers Mark Enyedy of Proteostasis, Edward Garmey of Cerulean Pharma and Hans Schikan of Prosensa.